CY1109141T1 - Χιμαιρικα σωματιδια παρομοια με αρτηριοϊους - Google Patents
Χιμαιρικα σωματιδια παρομοια με αρτηριοϊουςInfo
- Publication number
- CY1109141T1 CY1109141T1 CY20091100627T CY091100627T CY1109141T1 CY 1109141 T1 CY1109141 T1 CY 1109141T1 CY 20091100627 T CY20091100627 T CY 20091100627T CY 091100627 T CY091100627 T CY 091100627T CY 1109141 T1 CY1109141 T1 CY 1109141T1
- Authority
- CY
- Cyprus
- Prior art keywords
- chemical particles
- particles providing
- arteries
- structural protein
- arterial
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/10011—Arteriviridae
- C12N2770/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/10011—Arteriviridae
- C12N2770/10023—Virus like particles [VLP]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/10011—Arteriviridae
- C12N2770/10061—Methods of inactivation or attenuation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Plant Pathology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pulmonology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP00201780A EP1156111A1 (en) | 2000-05-19 | 2000-05-19 | Chimeric arterivirus-like particles |
| EP01932411A EP1283887B1 (en) | 2000-05-19 | 2001-05-21 | Chimeric arterivirus-like particles |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1109141T1 true CY1109141T1 (el) | 2014-07-02 |
Family
ID=8171523
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20091100627T CY1109141T1 (el) | 2000-05-19 | 2009-06-12 | Χιμαιρικα σωματιδια παρομοια με αρτηριοϊους |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US7122347B2 (enExample) |
| EP (2) | EP1156111A1 (enExample) |
| JP (1) | JP4875274B2 (enExample) |
| KR (1) | KR100916883B1 (enExample) |
| AT (1) | ATE426026T1 (enExample) |
| AU (1) | AU2001258938A1 (enExample) |
| CA (1) | CA2409209C (enExample) |
| CY (1) | CY1109141T1 (enExample) |
| DE (1) | DE60138014D1 (enExample) |
| DK (1) | DK1283887T3 (enExample) |
| ES (1) | ES2322237T3 (enExample) |
| MX (1) | MXPA02011415A (enExample) |
| PT (1) | PT1283887E (enExample) |
| WO (1) | WO2001090363A1 (enExample) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0839912A1 (en) | 1996-10-30 | 1998-05-06 | Instituut Voor Dierhouderij En Diergezondheid (Id-Dlo) | Infectious clones of RNA viruses and vaccines and diagnostic assays derived thereof |
| WO2000053787A1 (en) | 1999-03-08 | 2000-09-14 | Id-Lelystad, Instituut Voor Dierhouderij En Dierg Ezondheid B.V. | Prrsv vaccines |
| US20040224327A1 (en) * | 1996-10-30 | 2004-11-11 | Meulenberg Johanna Jacoba Maria | Infectious clones of RNA viruses and vaccines and diagnostic assays derived thereof |
| EP2251419B1 (en) | 1999-04-22 | 2012-05-30 | United States Department of Agriculture | Porcine reproductive and respiratory syndrome vaccine, based on isolate JA-142 |
| EP1421184A2 (en) * | 2001-03-09 | 2004-05-26 | Boehringer Ingelheim Vetmedica Gmbh | Live attenuated strains of prrs virus |
| EP1438969A1 (en) * | 2003-01-14 | 2004-07-21 | Universiteit Utrecht | Arterivirus marker vaccine |
| JP2008503727A (ja) | 2004-06-18 | 2008-02-07 | リージェンツ オブ ザ ユニバーシティ オブ ミネソタ | ウイルス感染した生物およびワクチン接種した生物の同定 |
| US7632636B2 (en) | 2004-09-21 | 2009-12-15 | Boehringer Ingelheim Vetmedica, Inc. | Porcine reproductive and respiratory syndrome isolates and methods of use |
| EP2369001B1 (en) | 2005-06-24 | 2016-08-31 | Regents of the University of Minnesota | PRRS viruses, infectious clones, mutants thereof, and methods of use |
| US9216212B2 (en) * | 2005-08-05 | 2015-12-22 | University Of Massachusetts | Virus-like particles as vaccines for paramyxovirus |
| US7951384B2 (en) * | 2005-08-05 | 2011-05-31 | University Of Massachusetts | Virus-like particles as vaccines for paramyxovirus |
| CN101495138B (zh) * | 2005-11-29 | 2014-01-08 | 衣阿华州立大学研究基金公司 | 猪繁殖与呼吸综合征病毒（prrsv）的保护性抗原决定子的鉴定及其用途 |
| US8142788B2 (en) * | 2007-04-30 | 2012-03-27 | Mj Biologics, Inc. | PRRSV GP5 based compositions and methods |
| US7666585B2 (en) * | 2007-06-15 | 2010-02-23 | Protatek International, Inc. | Construction of chimera PRRSV, compositions and vaccine preparations |
| WO2010025109A1 (en) * | 2008-08-25 | 2010-03-04 | Boehringer Ingelheim Vetmedia, Inc. | Vaccine against highly pathogenic porcine reproductive and respiratory syndrome (hp prrs) |
| WO2010039224A2 (en) | 2008-09-30 | 2010-04-08 | University Of Massachusetts Medical School | Respiratory syncytial virus (rsv) sequences for protein expression and vaccines |
| EP2230246A1 (en) * | 2009-03-19 | 2010-09-22 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Arterivirus glycoprotein 5 virus-like particles |
| AR078253A1 (es) | 2009-09-02 | 2011-10-26 | Boehringer Ingelheim Vetmed | Metodos para reducir la actividad antivirica en composiciones pcv-2 y composiciones pcv-2 con mejor inmunogenicidad |
| SG192820A1 (en) | 2011-02-17 | 2013-09-30 | Boehringer Ingelheim Vetmed | Novel european prrsv strain |
| CN103370077B (zh) | 2011-02-17 | 2016-10-26 | 贝林格尔.英格海姆维特梅迪卡有限公司 | 猪繁殖与呼吸综合征病毒的商业化规模生产方法 |
| US9187731B2 (en) | 2011-07-29 | 2015-11-17 | Boehringer Ingelheim Vetmedica Gmbh | PRRS virus inducing type I interferon in susceptible cells |
| EP2737058A1 (en) | 2011-07-29 | 2014-06-04 | Boehringer Ingelheim Vetmedica GmbH | INFECTIOUS cDNA CLONE OF EUROPEAN PRRS VIRUS AND USES THEREOF |
| CN102908617A (zh) * | 2011-08-04 | 2013-02-06 | 广州格拉姆生物科技有限公司 | 一种猪繁殖与呼吸综合症病毒m蛋白与cd40l融合疫苗及制备方法 |
| CN105073130A (zh) | 2013-03-15 | 2015-11-18 | 勃林格殷格翰动物保健公司 | 猪生殖与呼吸综合征病毒、组合物、疫苗及使用方法 |
| MX375528B (es) | 2013-12-20 | 2025-03-06 | Boehringer Ingelheim Vetmedica Gmbh | Variante del virus prrs, clon de adnc del virus europeo y sus usos. |
| CA2957513A1 (en) | 2014-08-08 | 2016-02-11 | Idemitsu Kosan Co., Ltd. | Agent for controlling porcine reproductive and respiratory syndrome |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2102971B1 (es) * | 1996-01-25 | 1998-03-01 | Hipra Lab Sa | Nueva cepa atenuada del virus causante del sindrome respiratorio y reproductivo porcino (prrs), las vacunas y medios de diagnostico obtenibles con la misma y los procedimientos para su obtencion. |
| EP0839912A1 (en) * | 1996-10-30 | 1998-05-06 | Instituut Voor Dierhouderij En Diergezondheid (Id-Dlo) | Infectious clones of RNA viruses and vaccines and diagnostic assays derived thereof |
| WO2000053787A1 (en) * | 1999-03-08 | 2000-09-14 | Id-Lelystad, Instituut Voor Dierhouderij En Dierg Ezondheid B.V. | Prrsv vaccines |
| WO1998055626A2 (en) * | 1997-06-05 | 1998-12-10 | Origen, Inc. | Recombinant porcine reproductive and respiratory syndrome virus (prrsv) for use as a vaccine |
-
2000
- 2000-05-19 EP EP00201780A patent/EP1156111A1/en not_active Withdrawn
-
2001
- 2001-05-21 DK DK01932411T patent/DK1283887T3/da active
- 2001-05-21 JP JP2001587157A patent/JP4875274B2/ja not_active Expired - Fee Related
- 2001-05-21 MX MXPA02011415A patent/MXPA02011415A/es active IP Right Grant
- 2001-05-21 EP EP01932411A patent/EP1283887B1/en not_active Expired - Lifetime
- 2001-05-21 PT PT01932411T patent/PT1283887E/pt unknown
- 2001-05-21 AT AT01932411T patent/ATE426026T1/de active
- 2001-05-21 WO PCT/NL2001/000382 patent/WO2001090363A1/en not_active Ceased
- 2001-05-21 CA CA2409209A patent/CA2409209C/en not_active Expired - Fee Related
- 2001-05-21 ES ES01932411T patent/ES2322237T3/es not_active Expired - Lifetime
- 2001-05-21 DE DE60138014T patent/DE60138014D1/de not_active Expired - Lifetime
- 2001-05-21 AU AU2001258938A patent/AU2001258938A1/en not_active Abandoned
- 2001-05-21 KR KR1020027015538A patent/KR100916883B1/ko not_active Expired - Fee Related
-
2002
- 2002-11-19 US US10/300,699 patent/US7122347B2/en not_active Expired - Lifetime
-
2009
- 2009-06-12 CY CY20091100627T patent/CY1109141T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1283887B1 (en) | 2009-03-18 |
| ES2322237T3 (es) | 2009-06-18 |
| MXPA02011415A (es) | 2004-02-26 |
| DK1283887T3 (da) | 2009-06-22 |
| KR20030026931A (ko) | 2003-04-03 |
| WO2001090363A1 (en) | 2001-11-29 |
| CA2409209C (en) | 2011-08-09 |
| AU2001258938A1 (en) | 2001-12-03 |
| EP1283887A1 (en) | 2003-02-19 |
| JP2004506411A (ja) | 2004-03-04 |
| CA2409209A1 (en) | 2001-11-29 |
| JP4875274B2 (ja) | 2012-02-15 |
| KR100916883B1 (ko) | 2009-09-09 |
| PT1283887E (pt) | 2009-03-31 |
| EP1156111A1 (en) | 2001-11-21 |
| ATE426026T1 (de) | 2009-04-15 |
| DE60138014D1 (de) | 2009-04-30 |
| US20030161845A1 (en) | 2003-08-28 |
| US7122347B2 (en) | 2006-10-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1109141T1 (el) | Χιμαιρικα σωματιδια παρομοια με αρτηριοϊους | |
| EA200801798A1 (ru) | Виросомоподобные везикулы, содержащие антигены, производные от gp41 | |
| CY1108299T1 (el) | Πεπτιδια του ιου ανθρωπινης ανοσοανεπαρκειας (hiv), αντιγονα και συνθεσεις εμβολιου | |
| BR0111732A (pt) | Prodrogas de 2-deóxi-beta-l-nucleosìdeos | |
| ATE419872T1 (de) | Vorbeugende und therapeutsche monoklonale antikörper gegen vacciniavirusantigene | |
| CY1106207T1 (el) | Αντιιικα παραγωγα νουκλεοζιτων | |
| ID27457A (id) | Komposisi untuk pengobatan hiv dan infeksi virus lainnya | |
| BR9712289A (pt) | Composições e métodos para o tratamento de infecções virais | |
| WO2001081421A3 (en) | Synthetic peptides that bind to the hepatitis b virus core and e antigens | |
| CY1111613T1 (el) | Μεθοδοι για την αντιμετωπιση της μολυνσης απο hiv | |
| BR0309581A (pt) | Derivados de nucleosìdeo para tratamento de infecção por vìrus de hepatite c | |
| DE60139127D1 (de) | Von hepatitis c virus | |
| HUP9802819A2 (hu) | Hősokkfehérje-alapú oltóanyagok és immunterápiák | |
| ATA157699A (de) | Faktor ix/faktor ixa aktivierende antikörper und antikörper-derivate | |
| ATE320493T1 (de) | Modifizierung des hepatitis b kernantigens | |
| DK1362109T3 (da) | Rekombinante oligomere protein-komplekser med foröget immunogent potentiale | |
| ATE555794T1 (de) | Heilmittel gegen hepatitis | |
| CY1112740T1 (el) | ΧΡΗΣΗ ΔΕΝΔΡΙΤΙΚΩΝ ΚΥΤΤΑΡΩΝ (DCs) ΕΚΦΡΑΖΟΝΤΑΣ ΙΝΤΕΡΛΕΥΚΙΝΗ 12 (IL-12) | |
| EP1649053A4 (en) | CHARACTERIZATION OF THE EARLY LEVELS OF THE VIRUS OF HEAVY ACUTE RESPIRATORY SYNDROME (SARS) AND USES THEREOF | |
| CY1107322T1 (el) | Συνδυασμενο εμβολιο κατα της hπατιτιδας α και ηπατιτιδας β | |
| DE69525659D1 (de) | Grippe-impfstoff | |
| DE69906568D1 (de) | Behandlung von hämorrhagischem virusfieber mit protein c | |
| EP1301208A4 (en) | Vaccine | |
| CL2010001175A1 (es) | Composicion de vacuna que comprende un antigeno de proteina viral 2 (vp-2) del virus causante de la enfermedad de la bursitis infecciosa (ibdv). | |
| EA200701870A1 (ru) | Пептид, происходящий из вируса гепатита с |